IL165670A0 - Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance - Google Patents

Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance

Info

Publication number
IL165670A0
IL165670A0 IL16567004A IL16567004A IL165670A0 IL 165670 A0 IL165670 A0 IL 165670A0 IL 16567004 A IL16567004 A IL 16567004A IL 16567004 A IL16567004 A IL 16567004A IL 165670 A0 IL165670 A0 IL 165670A0
Authority
IL
Israel
Prior art keywords
thetreatment
ortho
benzoic acid
acid derivatives
insulin resistance
Prior art date
Application number
IL16567004A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL165670A0 publication Critical patent/IL165670A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16567004A 2002-06-20 2004-12-09 Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance IL165670A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201936A SE0201936D0 (sv) 2002-06-20 2002-06-20 Therapeutic agents
PCT/GB2003/002591 WO2004000294A1 (en) 2002-06-20 2003-06-17 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance

Publications (1)

Publication Number Publication Date
IL165670A0 true IL165670A0 (en) 2006-01-15

Family

ID=20288294

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16567004A IL165670A0 (en) 2002-06-20 2004-12-09 Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance

Country Status (26)

Country Link
EP (1) EP1517679B1 (pl)
JP (1) JP2005535618A (pl)
KR (1) KR20050014015A (pl)
CN (1) CN1307988C (pl)
AR (1) AR039714A1 (pl)
AT (1) ATE385790T1 (pl)
AU (1) AU2003240100B2 (pl)
BR (1) BR0311839A (pl)
CA (1) CA2490684A1 (pl)
DE (1) DE60319082T2 (pl)
DK (1) DK1517679T3 (pl)
ES (1) ES2299703T3 (pl)
HK (1) HK1074779A1 (pl)
IL (1) IL165670A0 (pl)
IS (1) IS7626A (pl)
MX (1) MXPA04012685A (pl)
NO (1) NO20045223L (pl)
NZ (1) NZ536971A (pl)
PL (1) PL375080A1 (pl)
PT (1) PT1517679E (pl)
RU (1) RU2288912C2 (pl)
SE (1) SE0201936D0 (pl)
TW (1) TW200407114A (pl)
UA (1) UA76627C2 (pl)
WO (1) WO2004000294A1 (pl)
ZA (1) ZA200409693B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
DE60319084T2 (de) 2002-06-20 2009-01-29 Astrazeneca Ab Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz
PL219045B1 (pl) * 2010-10-16 2015-03-31 Inst Chemii Organicznej Polskiej Akademii Nauk Nowe estry (acyloksymetylo)akrylamidu, kompozycja farmaceutyczna zawierająca je oraz ich zastosowanie
WO2017160922A1 (en) 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
JP4618845B2 (ja) * 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体
US6509374B2 (en) * 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use

Also Published As

Publication number Publication date
ZA200409693B (en) 2005-10-11
AR039714A1 (es) 2005-03-09
CN1674883A (zh) 2005-09-28
AU2003240100B2 (en) 2006-06-01
JP2005535618A (ja) 2005-11-24
NZ536971A (en) 2006-05-26
DK1517679T3 (da) 2008-05-19
RU2004135543A (ru) 2005-08-10
ATE385790T1 (de) 2008-03-15
HK1074779A1 (en) 2005-11-25
KR20050014015A (ko) 2005-02-05
SE0201936D0 (sv) 2002-06-20
CN1307988C (zh) 2007-04-04
BR0311839A (pt) 2005-04-05
RU2288912C2 (ru) 2006-12-10
ES2299703T3 (es) 2008-06-01
NO20045223L (no) 2005-03-17
EP1517679A1 (en) 2005-03-30
DE60319082D1 (de) 2008-03-27
UA76627C2 (en) 2006-08-15
WO2004000294A1 (en) 2003-12-31
AU2003240100A1 (en) 2004-01-06
DE60319082T2 (de) 2009-01-29
TW200407114A (en) 2004-05-16
PL375080A1 (pl) 2005-11-14
EP1517679B1 (en) 2008-02-13
IS7626A (is) 2005-01-05
PT1517679E (pt) 2008-04-21
MXPA04012685A (es) 2005-03-23
CA2490684A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
IL173522A0 (en) Phenoxyacetic acid derivatives
IL175550A0 (en) Heterocyclic boronic acid compounds
SI1488790T1 (sl) Trden pripravek, ki vsebuje eno samo kristalno a-obliko derivata tiazolkarboksilne kisline
EP1510207A4 (en) THERAPEUTIC MEDICAMENT AGAINST DIABETES
NO20020764L (no) Benzosyrederivater for behandling av diabetes mellitus
AU2003264005A1 (en) Antibacterial benzoic acid derivatives
AU2003211131A1 (en) Metformin salts of lipophilic acids
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
HK1073838A1 (en) Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance
AU2003265382A8 (en) Antibacterial benzoic acid derivatives
AU2003257162A1 (en) Catheter for cardiac injection
HK1074779A1 (en) Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance
PL372616A1 (pl) Pochodne kwasu fenylo(alkilo)karboksylowego i pochodne dijonowe fenyloalkiloheterocykliczne oraz ich zastosowanie jako leków o aktywności obniżającejglukozy surowiczej i/lub lipidów surowiczych
IL164413A0 (en) (2-((-Alkoxy)-phenyl)-cyclopent-1-enyl)aromatic carbo and heterocyclic acid and derivatives
SI1517679T1 (sl) Orto-substituirani derivati benzojske kisline za zdravljenje insulinske rezistence
SI1517883T1 (sl) Orto-substituirani derivati benzojske kisline za zdravljenje insulinske rezistence
EP1549617A4 (en) SALT OF AMLODIPIN WITH AN ORGANIC ACID
SG107315A1 (en) Use of conjugated linoleic acid derivatives
EP1549616A4 (en) SALT OF AMLODIPIN WITH AN ORGANIC SOURCE
ZA200605302B (en) Use of pentadienoic acid derivatives for the treatment of hyperuricemia
SI1620085T1 (sl) Uporaba derivatov fenoksiocetne kisline za zdravljenje hiperaktivnega sečnega mehurja
AU2003231527A8 (en) Novel derivatives of carnosic acid
GB0227205D0 (en) Heat sensitive composition comprising benzoic acid derivatives
EP1537866A4 (en) MEDICAMENTS AGAINST NIERENINSUFFIZIENZ WITH OXALURSUUREDERIVATEN
AU2003280519A8 (en) 2-pyridin acetic acid derivatives with antiproliferative activity